Glenmark reaches $15.2 million settlement with Humana in US generic drug antitrust case

In an intimation the stock exchange, the Mumbai-based drugmaker said, “it has agreed to enter into a settlement with insurance company, Humana for the total amount of $15.28 million, including interest, payable in two installments.”